トップ > 製品検索結果一覧
| クリップ | Code No. | 品名 | データ | ||||
|---|---|---|---|---|---|---|---|
| データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
| 配列 | 位置 | 温度 | |||||
|
|
|||||||
|
TB-5113-1 |
H-2Db Adpgk Neoepitope Tetramer-ASMTNMELM-PE |
|
||||
| cancer | PE | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ASMTNMELM | 4°C | ||||||
|
|
TS-M546-2 |
H-2Db gp100 Tetramer-EGSRNQDWL-APC |
|
||||
|
cancer | APC | H-2Db | 50 tests | ￥209,000 | 1-9 | |
| EGSRNQDWL | 25-33 | 4°C | |||||
|
|
TB-5004-4 |
T-Select H-2Kb TRP-2 Tetramer-SVYDFFVWL-BV421 |
|
||||
| cancer | BV421 | H-2Kb | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SVYDFFVWL | 180-188 | 4°C | |||||
|
|
TB-5114-2 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-APC |
|
||||
| cancer | APC | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| AQLANDVVL | 4°C | ||||||
|
|
TB-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RMPEAAPPV | 65-73 | 4°C | |||||
|
|
TS-M016-2 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| RMFPNAPYL | 126-134 | 4°C | |||||
|
|
TB-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLFFYRKSV | 4°C | ||||||
|
|
TS-M545-1 |
H-2Kd Erk2 K136Q Tetramer-QYIHSANVL-PE |
|
||||
|
|
cancer | PE | H-2Kd | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| QYIHSANVL | 136-144 | 4°C | |||||
|
|
TB-M075-1 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KVAELVHFL | 112-120 | 4°C | |||||
|
|
TB-0110-4 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLLFLLFSL | 4°C | ||||||
|
|
TB-0140-2 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-APC |
|
||||
| cancer | APC | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EYILSLEEL | 298-306 | 4°C | |||||
|
|
TS-TCR01-1 |
Human TCR Tetramer-PE (HLA-A*24:02 survivin-2B80-88-AYACNTSTL) |
|
||||
|
|
cancer | PE | 50 tests | ￥275,000 |
0 (お問合せ） |
||
| 4°C | |||||||
|
|
TB-5114-4 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-BV421 |
|
||||
| cancer | BV421 | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| AQLANDVVL | 4°C | ||||||
|
|
TS-M091-2 |
HLA-A*24:02 MCPyV large T Ag Tetramer-EWWRSGGFSF-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EWWRSGGFSF | 92-101 | 4°C | |||||
|
|
TB-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLYDDNQRV | 828-836 | 4°C | |||||
|
|
TS-M077-2 |
HLA-A*24:02 MAGE-A3 Tetramer-IMPKAGLLI-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| IMPKAGLLI | 195-203 | 4°C | |||||
|
|
TB-5104-2 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-APC |
|
||||
| cancer | APC | H-2Kd | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SYMLQALCI | 4°C | ||||||
|
|
TB-5102-2 |
H-2Kb Survivin Tetramer-MFFCFKEL-APC |
|
||||
| cancer | APC | H-2Kb | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| MFFCFKEL | 4°C | ||||||
|
|
TB-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
|
||||
| cancer | PE | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
|
TB-0164-2 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YMCSFLFNL | 666-674 | 4°C | |||||
|
|
TB-0119-4 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-BV421 |
|
||||
| cancer | BV421 | B*07:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| LPWHRLFLL | 208-216 | 4°C | |||||
|
|
TS-M519-1 |
T-Select H-2Ld P815 Tetramer-LPYLGWLVF-PE |
|
||||
|
|
cancer | PE | H-2Ld | 50 tests | ￥209,000 | 1-9 | |
| LPYLGWLVF | 35-43 | 4°C | |||||
|
|
TB-5113-2 |
H-2Db Adpgk Neoepitope Tetramer-ASMTNMELM-APC |
|
||||
| cancer | APC | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ASMTNMELM | 4°C | ||||||
|
|
TB-M505-4 |
T-Select H-2Db human gp 100 Tetramer-KVPRNQDWL-BV421 |
|
||||
| cancer | BV421 | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KVPRNQDWL | 25-33 | 4°C | |||||
|
|
TB-0129-2 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-APC |
|
||||
| cancer | APC | B*35:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| MPFATPMEA | 94-102 | 4°C | |||||
|
|
TB-5105-2 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-APC |
|
||||
| cancer | APC | H-2Kd | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SYVKVLHHM | 4°C | ||||||
|
|
TB-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VLAGGFFLL | 27-38 | 4°C | |||||
|
|
TS-M079-2 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| KASEKIFYV | 41-49 | 4°C | |||||
|
|
TB-M076-1 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLWGPRALV | 271-279 | 4°C | |||||
|
|
TB-5114-1 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-PE |
|
||||
| cancer | PE | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| AQLANDVVL | 4°C | ||||||
|
|
TB-5115-1 |
H-2Db Copine-1 Neoepitope Tetramer-SSPYSLHYL-PE |
|
||||
| cancer | PE | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SSPYSLHYL | 4°C | ||||||
|
|
TB-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTV | 4°C | ||||||
|
|
TB-M074-4 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-BV421 |
|
||||
| cancer | BV421 | A*01:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EVDPIGHLY | 168-176 | 4°C | |||||
|
|
TS-M091-1 |
HLA-A*24:02 MCPyV large T Ag Tetramer-EWWRSGGFSF-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EWWRSGGFSF | 92-101 | 4°C | |||||
|
|
TS-M544-2 |
H-2Kd JAK1 Tetramer-SYFPEITHI-APC |
|
||||
|
|
cancer | APC | H-2Kd | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| SYFPEITHI | 367-375 | 4°C | |||||
|
|
TB-0108-4 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-BV421 |
|
||||
| cancer | BV421 | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RISTFKNWPK | 4°C | ||||||
|
|
TB-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLWGPRALV | 271-279 | 4°C | |||||
|
|
TB-0009-4 |
T-Select HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ELAGIGILTV | 26-35 | 4°C | |||||
|
|
TB-0167-4 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-BV421 |
|
||||
| cancer | BV421 | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
|
TB-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RMPEAAPPV | 65-73 | 4°C | |||||
|
|
TS-M544-1 |
H-2Kd JAK1 Tetramer-SYFPEITHI-PE |
|
||||
|
|
cancer | PE | H-2Kd | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| SYFPEITHI | 367-375 | 4°C | |||||
|
|
TB-5102-4 |
H-2Kb Survivin Tetramer-MFFCFKEL-BV421 |
|
||||
| cancer | BV421 | H-2Kb | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| MFFCFKEL | 4°C | ||||||
|
|
TB-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLFFYRKSV | 4°C | ||||||
|
|
TB-M011-4 |
T-Select HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLLMWITQC | 157-165 | 4°C | |||||
|
|
TB-0157-2 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RMPEAAPPV | 65-73 | 4°C | |||||
|
|
TB-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| GLAPPQHLIRV | 187-197 | 4°C | |||||
|
|
TB-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| AILALLPAL | 105-133 | 4°C | |||||
|
|
TB-0126-1 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-PE |
|
||||
| cancer | PE | A*01:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KSDICTDEY | 243-251 | 4°C | |||||
|
|
TS-M083-1 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| KLQDASAEV | 126-134 | 4°C | |||||
|
|
TS-M083-2 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| KLQDASAEV | 126-134 | 4°C | |||||
|
|
TS-M089-2 |
HLA-A*24:02 gp100-intron 4 Tetramer-VYFFLPDHL-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| VYFFLPDHL | 170-178 | 4°C | |||||
|
|
TS-M112-2 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EYRALQLHL | 219-227 | 4°C | |||||
|
|
TB-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTA | 280-288 | 4°C | |||||
|
|
TB-0105-1 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-PE |
|
||||
| cancer | PE | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KLFGVLRLK | 4°C | ||||||
|
|
TB-M014-4 |
HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-BV421 |
|
||||
| cancer | BV421 | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| CYTWNQMNL | 235-243 | 4°C | |||||
|
|
TB-0017-4 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| VLQELNVTV | 169-177 | 4°C | |||||
|
|
TB-0167-2 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-APC |
|
||||
| cancer | APC | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RYCNLEGPPI | 177-186 | 4°C | |||||
|
|
TB-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLPPPGTRV | 149-157 | 4°C | |||||
|
|
TB-0129-1 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-PE |
|
||||
| cancer | PE | B*35:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| MPFATPMEA | 94-102 | 4°C | |||||
|
|
TS-M073-2 |
HLA-A*24:02 MAGE-A2 Tetramer-EYLQLVFGI-APC |
|
||||
|
|
cancer | APC | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EYLQLVFGI | 156-164 | 4°C | |||||
|
|
TS-M081-1 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 | 1-9 | |
| LLGRNSFEV | 264-272 | 4°C | |||||
|
|
TS-M545-2 |
H-2Kd Erk2 K136Q Tetramer-QYIHSANVL-APC |
|
||||
|
|
cancer | APC | H-2Kd | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| QYIHSANVL | 136-144 | 4°C | |||||
|
|
TB-5115-4 |
H-2Db Copine-1 Neoepitope Tetramer-SSPYSLHYL-BV421 |
|
||||
| cancer | BV421 | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SSPYSLHYL | 4°C | ||||||
|
|
TB-5105-1 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-PE |
|
||||
| cancer | PE | H-2Kd | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SYVKVLHHM | 4°C | ||||||
|
|
TB-5102-1 |
H-2Kb Survivin Tetramer-MFFCFKEL-PE |
|
||||
| cancer | PE | H-2Kb | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| MFFCFKEL | 4°C | ||||||
|
|
TB-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YLEPGPVTV | 4°C | ||||||
|
|
TB-0108-1 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-PE |
|
||||
| cancer | PE | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RISTFKNWPK | 4°C | ||||||
|
|
TB-M070-4 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KVLEYVIKV | 278-286 | 4°C | |||||
|
|
TB-M016-4 |
T-Select HLA-A*02:01 WT-1126-134 Tetramer-RMFPNAPYL-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RMFPNAPYL | 126-134 | 4°C | |||||
|
|
TB-0019-4 |
T-Select HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| YMDGTMSQV | 368-376 | 4°C | |||||
|
|
TB-0015-4 |
T-Select HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KIFGSLAFL | 369-377 | 4°C | |||||
|
|
TB-0014-4 |
T-Select HLA-A*02:01 gp100 (Wild) Tetramer-ITDQVPFSV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ITDQVPFSV | 209-217 | 4°C | |||||
|
|
TB-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| GLAPPQHLIRV | 187-197 | 4°C | |||||
|
|
TS-M078-2 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| GLYDGMEHL | 254-262 | 4°C | |||||
|
|
TS-M079-1 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| KASEKIFYV | 41-49 | 4°C | |||||
|
|
TS-M084-2 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-APC |
|
||||
|
|
cancer | APC | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TLADFDPRV | 883-891 | 4°C | |||||
|
|
TS-M112-1 |
HLA-A*24:02 CA9219-227 Tetramer-EYRALQLHL-PE |
|
||||
|
|
cancer | PE | A*24:02 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EYRALQLHL | 219-227 | 4°C | |||||
|
|
TS-M518-1 |
T-Select H-2Db CEA Tetramer-EAQNTTYL-PE |
|
||||
|
|
cancer | PE | H-2Db | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| EAQNTTYL | 526-533 | 4°C | |||||
|
|
TB-5115-2 |
H-2Db Copine-1 Neoepitope Tetramer-SSPYSLHYL-APC |
|
||||
| cancer | APC | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SSPYSLHYL | 4°C | ||||||
|
|
TB-5104-4 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-BV421 |
|
||||
| cancer | BV421 | H-2Kd | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SYMLQALCI | 4°C | ||||||
|
|
TB-0166-1 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-PE |
|
||||
| cancer | PE | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ALLAVGATK | 4°C | ||||||
|
|
TB-0108-2 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-APC |
|
||||
| cancer | APC | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| RISTFKNWPK | 4°C | ||||||
|
|
TB-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLLMWITQV | 157-165 | 4°C | |||||
|
|
TB-0035-4 |
T-Select HLA-A*02:01 gp100 154-162 Tetarmer-KTWGQYWQV-BV421 |
|
||||
| cancer | BV421 | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KTWGQYWQV | 154-162 | 4°C | |||||
|
|
TB-5108-4 |
H-2Db Survivin Tetramer-ATFKNWPFL-BV421 |
|
||||
| cancer | BV421 | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ATFKNWPFL | 20-28 | 4°C | |||||
|
|
TB-5108-1 |
H-2Db Survivin Tetramer-ATFKNWPFL-PE |
|
||||
| cancer | PE | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ATFKNWPFL | 20-28 | 4°C | |||||
|
|
TB-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLFLGILSV | 188-196 | 4°C | |||||
|
|
TB-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| KLCPVQLWV | 139-147 | 4°C | |||||
|
|
TB-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| GLQHWVPEL | 97-106 | 4°C | |||||
|
|
TB-0140-4 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-BV421 |
|
||||
| cancer | BV421 | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EYILSLEEL | 298-306 | 4°C | |||||
|
|
TB-0140-1 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-PE |
|
||||
| cancer | PE | A*24:02 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| EYILSLEEL | 298-306 | 4°C | |||||
|
|
TB-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|
||||
| cancer | APC | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| FLYDDNQRV | 828-836 | 4°C | |||||
|
|
TB-0127-1 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| AILALLPAL | 105-133 | 4°C | |||||
|
|
TS-M084-1 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE |
|
||||
|
|
cancer | PE | A*02:01 | 50 tests | ￥209,000 |
0 (お問合せ） |
|
| TLADFDPRV | 883-891 | 4°C | |||||
|
|
TB-0013-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (IMDQVPFSV)
|
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| IMDQVPFSV | 209-217 | 4°C | |||||
|
|
TB-0014-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (ITDQVPFSV)
|
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ITDQVPFSV | 209-217 | 4°C | |||||
|
|
TB-5113-4 |
H-2Db Adpgk Neoepitope Tetramer-ASMTNMELM-BV421 |
|
||||
| cancer | BV421 | H-2Db | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ASMTNMELM | 4°C | ||||||
|
|
TB-5104-1 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-PE |
|
||||
| cancer | PE | H-2Kd | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SYMLQALCI | 4°C | ||||||
|
|
TB-0166-2 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-APC |
|
||||
| cancer | APC | A*03:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| ALLAVGATK | 4°C | ||||||
|
|
TB-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
|
||||
| cancer | PE | A*02:01 | 50 tests | ￥190,000 |
0 (お問合せ） |
||
| SLLFLLFSL | 4°C | ||||||
※在庫につきましては2024年04月19日 00時05分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について： RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。